FOLINIC ACID CALCIUM SALT PENTAHYDRATE CAS 41927-89-3
Introduction:Basic information about FOLINIC ACID CALCIUM SALT PENTAHYDRATE CAS 41927-89-3, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
FOLINIC ACID CALCIUM SALT PENTAHYDRATE Basic information
| Product Name: | FOLINIC ACID CALCIUM SALT PENTAHYDRATE |
| Synonyms: | 5-FORMYL-5,6,7,8-TETRAHYDROFOLIC ACID CALCIUM SALT;5-FORMYL-5,6,7,8-TETRAHYDROFOLIC ACID CALCIUM SALT PENTAHYDRATE;5-FORMYL-5,6,7,8-TETRAHYDROPTEROYL-L-GLUTAMIC ACID CALCIUM SALT PENTAHYDRATE;5-HCO-H4PTEGLU CALCIUM SALT PENTAHYDRATE;CALCIUM FOLINATE PENTAHYDRATE;LEUCOVORIN CALCIUM SALT PENTAHYDRATE;LEUCOVORIN PENTAHYDRATE;FOLINIC ACID CALCIUM SALT PENTAHYDRATE |
| CAS: | 41927-89-3 |
| MF: | C20H31CaN7O12 |
| MW: | 601.58 |
| EINECS: | |
| Product Categories: | |
| Mol File: | 41927-89-3.mol |
FOLINIC ACID CALCIUM SALT PENTAHYDRATE Chemical Properties
| Melting point | 240-250 °C |
| storage temp. | 0-6°C |
| solubility | Aqueous (Slightly, Sonicated), Water (Sparingly, Heated, Sonicated) |
| form | Solid |
| color | Off-White to Pale Yellow |
| Stability: | Hygroscopic |
Safety Information
| Safety Statements | 24/25 |
| Uses | Anti-anemic (folate deficiency); antidote (to folic acidantagonists). |
| Brand name | Wellcovorin (GlaxoSmithKline). |
| Clinical Use | Folinic acid rescue Enhancement of 5-fluorouracil cytotoxicity inadvanced colorectal cancer Folate deficiency |
| Drug interactions | Potentially hazardous interactions with other drugs Should not be administered simultaneously with afolic acid antagonist as this may nullify the effect ofthe antagonist. Cytotoxics: avoid with panitumumab and raltitrexed. |
| Metabolism | Folinic acid is a racemate where the L-form (L-5-formyl-tetrahydrofolate, L-5-formyl-THF), is the activeenantiomer. The major metabolic product of folinic acidis 5-methyl-tetrahydrofolic acid (5-methyl-THF) whichis predominantly produced in the liver and intestinalmucosa. 80-90% with the urine (5- and 10-formyltetrahydrofolatesinactive metabolites), 5-8% with thefaeces. |
